Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
about
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDUnderdiagnosis of Attention-Deficit/Hyperactivity Disorder in Adult PatientsTreatment of adults with attention-deficit/hyperactivity disorderTreatment of adults with attention-deficit/hyperactivity disorderOptimal management of ADHD in older adultsRates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units.The impact of depressive symptoms in adults with ADHD symptoms on family function and ADHD symptoms of their children.Mediating Effect of Depressive Symptoms on the Relationship between Adult Attention Deficit Hyperactivity Disorder and Quality of Life.Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC.The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan.The increased risk of road crashes in attention deficit hyperactivity disorder (ADHD) adult drivers: driven by distraction? Results from a responsibility case-control study.Comorbidity of attention deficit hyperactivity disorder with personality disorders in homeless peopleMindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial.Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover StudyDevelopmental course of attention deficit hyperactivity disorder and its predictors.Are Eating Disorders Related to Attention Deficit/Hyperactivity Disorder?Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination.Emerging drugs for attention-deficit/hyperactivity disorder.Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHDMortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study.Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD).Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder.Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective.Attention Deficit/Hyperactivity Disorder symptoms and cognitive abilities in the late-life cohort of the PATH through life study.OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins.Managing ADHD across the lifespan in the primary care setting.The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents.Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder.Examining the effect of social bonds on the relationship between ADHD and past arrest in a representative sample of adults.The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5.Lifetime stability of ADHD symptoms in older adults.Psychiatric Comorbidities in a New Zealand Sample of Adults With ADHD.The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.Delayed sleep timing and symptoms in adults with attention-deficit/hyperactivity disorder: a controlled actigraphy study.Probabilities of ADD/ADHD and Related Substance Use Among Canadian Adults.Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities.The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.Discriminating among ADHD alone, ADHD with a comorbid psychological disorder, and feigned ADHD in a college sample.
P2860
Q21260332-83C29FC3-86EB-4FCB-8119-53F0A7290543Q22241098-914F58E8-F505-43F5-879B-C7B57A4786CDQ24642937-9E1297F9-05D3-453E-B005-9EE04C72E673Q24644586-65D2B03F-68E8-4209-9F97-DCF289D4673FQ26774425-5E8B428F-E9F0-4AB0-B389-5B1AD3ED6965Q31108345-C90B18E4-F9E4-4E7D-AD90-CD20CD0CA7DAQ33620338-4DE981DC-87D9-4585-B702-47447CB2EDA2Q33620345-F09F10D5-2C9F-46FA-9A0F-DD40DA3615B6Q34056263-20E3EA71-B07A-4AB2-A617-F0F14130495BQ34681077-BB4C1F3D-DD66-4CAD-921B-735DAF6B5D6BQ34764601-8B30E6AF-A4E3-418D-A67D-9BC5B3FB17EEQ34990980-4B4D2BEA-1891-4590-A881-F8654863DCAEQ35494000-5C7634BD-EE81-40B8-9BF8-A4A54C183623Q35610253-16DCD311-CD69-4416-89A3-52067F6F5D50Q35807351-8280DC58-5E0C-465D-9BB3-BA6BF663B07AQ36591111-C1B3DB6C-2216-4E98-9465-9EB982018428Q36649080-E2519B5D-638D-493C-86D1-162183D021CCQ36722925-5E8C7B95-E57B-48AE-A37B-6430E2B896A4Q36944017-175DA60F-7DAF-41BD-B42F-F38328D8CFE4Q37224553-EF20D171-586A-4573-A5A8-75B3C1BCC14BQ37290084-C86EBCB6-7459-408E-B8F1-4A346081E483Q37299888-66565923-8127-4B6E-ACD7-2451B6EAB44EQ37320520-9EA6C0E9-B92B-438B-98E0-91073B24E81BQ37505871-AAD18835-7224-4930-8103-DCA6C5C86CCBQ37525346-E92421A0-26DF-4FCB-A417-4221E0199A0DQ37578475-2B6100C8-1CC9-465F-86CD-047159543126Q37662901-EE65324A-1168-43E7-A99C-91681FF0D3A9Q37929495-675A0D8B-E99D-487D-819A-CA55708C7533Q38023225-2C70FE18-C48F-44E3-B0EB-7231457B8CD5Q38689665-ED1B50D4-BFB8-4097-A835-06BF7716C9EAQ38693517-7C4AEF5E-76D8-4FA0-B6E9-066493D78545Q38849756-04D1811F-A025-48FF-9D86-259D2577AF3EQ38996291-26618664-DD6D-44C5-97AC-6BBC4E486323Q39216392-9A3B7A10-58D0-43E7-B943-7F5847CD3993Q39433708-48959C7B-DA9C-4A4E-9BDF-57BAE2DD11E4Q39460238-AB9FDDA8-1946-4F91-9D7B-835D68DD553AQ39766317-4A400BD2-2C4A-4524-B112-51365BA05330Q40207289-737FC3A8-4EF6-4E0D-92E3-ABD97132D34DQ42070708-036B3D60-1D1C-4495-9FF8-75909E705DFCQ44112040-EFEAC005-AAC4-4EAF-A0E0-39F27A998FAF
P2860
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
@ast
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
@en
type
label
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
@ast
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
@en
prefLabel
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
@ast
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
@en
P2860
P1476
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).
@en
P2093
Esther Sobanski
P2860
P2888
P304
P356
10.1007/S00406-006-1004-4
P478
256 Suppl 1
P577
2006-09-01T00:00:00Z